Purdue Sues KV Over OxyContin Patent
Less than two weeks after a Manhattan court entered a consent judgment that marked an end to a patent infringement battle over the painkiller OxyContin, OxyContin maker Purdue Pharma LP has...To view the full article, register now.
Already a subscriber? Click here to view full article